Q: Should N-acetylcysteine be used routinely to prevent contrast-induced acute kidney injury? (Record no. 22238623)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01211 a2200325 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516120840.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201310s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1939-2869 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.3949/ccjm.79a.12088 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Sivalingam, Senthil K |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20131021 |
| 245 00 - TITLE STATEMENT | |
| Title | Q: Should N-acetylcysteine be used routinely to prevent contrast-induced acute kidney injury? |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cleveland Clinic journal of medicine |
| Date of publication, distribution, etc. | Nov 2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 746-9 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Acetylcysteine |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Acute Kidney Injury |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Administration, Intravenous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anaphylaxis |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Contrast Media |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Practice Guidelines as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Risk Assessment |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hariharan, Mini V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Braden, Gregory L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Freda, Benjamin J |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cleveland Clinic journal of medicine |
| Related parts | vol. 79 |
| -- | no. 11 |
| -- | p. 746-9 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.3949/ccjm.79a.12088">https://doi.org/10.3949/ccjm.79a.12088</a> |
| Public note | Available from publisher's website |
No items available.